Back to search
FDAFDA · Food and drugs·Recall number D-0809-2021

Chantix (varenicline) tablets 0.5mg, 56 Tablets, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Ireland, NDC 0069-0468-56.

Published September 29, 2021 · Recall initiated: August 13, 2021

Summary

FDA records drug Class II recall D-0809-2021, published September 29, 2021 and initiated August 13, 2021. Recalling firm: Pfizer Inc.; Status: Ongoing; Lot: Lots , CY6861, DM9007, DM9008, EN5725, EN8362, EN8467 EXPIRATION DATE: January 2022 - May 2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit

What to do

Voluntary: Firm initiated · Press Release

Get an email if CHANTIX has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CHANTIX
Manufacturer
Pfizer Inc.
Distributor
Nationwide
UPC
0300690469560
Lot
Lots , CY6861, DM9007, DM9008, EN5725, EN8362, EN8467 EXPIRATION DATE: January 2022 - May 2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Chantix (varenicline) tablets 0.5mg, 56 Tablets, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Ireland, NDC 0069-0468-56. recalled?

Yes. FDA published recall D-0809-2021 on September 29, 2021. Reported hazard: CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CHANTIX. UPC: 0300690469560.